Covance, NeoGenomics to Jointly Offer Services for Clinical Trials | GenomeWeb

NEW YORK (GenomeWeb News) – Covance and NeoGenomics today announced a collaboration to jointly offer anatomic pathology and specialty laboratory testing services for clinical trials.

Covance will create a laboratory at NeoGenomics' facility in Fort Myers, Fla., and together they will provide a full range of anatomic pathology and histology services, including immunohistochemistry, fluorescence in situ hybridization, molecular testing, as well as tissue-based biomarkers and other specialty testing services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.